[Role of prostacyclin and thromboxane A2 in the cardiovascular system].
D000818:Animals; D001095:Arachidonic Acids / Q000378:metabolism; D001161:Arteriosclerosis / Q000503:physiopathology; D001794:Blood Pressure / Q000187:drug effects; D002320:Cardiovascular Physiological Phenomena; D003326:Coronary Circulation / Q000187:drug effects; D011464:Epoprostenol / Q000096:biosynthesis / Q000502:physiology*; D006801:Humans; D006973:Hypertension / Q000503:physiopathology; D010974:Platelet Aggregation / Q000187:drug effects; D011449:Prostaglandin Endoperoxides / Q000096:biosynthesis; D011453:Prostaglandins / Q000502:physiology*; D013923:Thromboembolism / Q000503:physiopathology; D013928:Thromboxane A2 / Q000096:biosynthesis / Q000502:physiology*; D013931:Thromboxanes / Q000502:physiology*; D014655:Vascular Resistance / Q000187:drug effects
D001095:Arachidonic Acids; D011449:Prostaglandin Endoperoxides; D011453:Prostaglandins; D013931:Thromboxanes; D013928:Thromboxane A2; D011464:Epoprostenol
Rol' prostatsiklina i tromboksana A2 v serdechno-sosudistoĭ sisteme.